Study of body markers in recurrent glioblastoma
Part of Cancer clinical trials.
This study looks at special markers in the blood and tumors of people whose glioblastoma has come back. It may help doctors understand why the cancer returns and how to treat it better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You had surgery for both your first glioblastoma and when it came back (recurrence) at the University Hospital of Bordeaux between 2005 and 2023.
- You have not received chemotherapy or other systemic treatment for a different type of cancer (not glioblastoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new kind of cell therapy called CAR-T, made from donor cells, to treat glioblastoma that has come back. The treatment targets a specific marker on the tumor (B7H3) and is injected into the brain to attack the cancer cells.
This trial tests an experimental drug called LMP744 for people whose glioblastoma has come back. It aims to see if the drug can slow or stop tumor growth by targeting specific proteins in cancer cells.
This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.
This study analyzes tissue and health-related biological data from people with glioblastoma to learn what’s happening in the tumor. The results may help improve future ways to understand and treat glioblastoma using advanced computer analysis.
This early study looks at a treatment plan (including resection/surgery and an added medicine) for glioblastoma that has come back after standard therapy. The goal is to see how well it controls tumor growth and whether it is tolerable.
This trial tests a combination of two drugs (D2C7-IT and 2141-V11) given directly into the brain after surgery for people with recurrent glioblastoma. The goal is to see if this treatment is safe and can help control the tumor.
Hear when a new Relapsed Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.